Lycia Therapeutics, Inc. (LYCA)

CIK 1806540 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lycia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202640001231919-26-001536
Oct 30, 202640001231919-26-001519
Oct 30, 2026SCHEDULE 13G0001738048-26-000077
Oct 28, 202640001193125-26-436415
Oct 27, 202640001231919-26-001503
Oct 26, 202640001750495-26-000007
Oct 26, 202640002159565-26-000005
Oct 26, 202640002050422-26-000017
Oct 26, 20268-K0001628280-26-067312
Oct 26, 202640001422304-26-000005
Oct 26, 202640001182471-26-000007
Oct 26, 202640002010805-26-000007
Oct 26, 202640002159567-26-000005
Oct 26, 202640001379344-26-000011
Oct 23, 2026S-80001628280-26-067067
Oct 23, 2026424B40001628280-26-067048
Oct 22, 2026S-1MEF0001628280-26-066940
Oct 22, 202630001193125-26-429267
Oct 22, 202630001193125-26-429196
Oct 22, 202630002159567-26-000003
Oct 22, 202630001379344-26-000009
Oct 22, 202630001231919-26-001493
Oct 22, 202630002159565-26-000003
Oct 22, 2026CERT0001354457-26-001015
Oct 22, 202630001698766-26-000006